Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Agenus Stock Is Crushing It Today

TheMotleyFool

0 0

Shares of clinical-stage immunotherapy company Agenus (NASDAQ: AGEN) were up by a healthy 18% as of 1:09 p.m. ET on Wednesday. Investors are bidding up the biotech's stock today following the release of its 2021 fourth-quarter and full-year earnings report.

What appears to really be moving the stock, though, is a price target upgrade by financial firm H.C. Wainwright. In response to the impressive clinical progress of Agenus' anti-cancer checkpoint inhibitor platform, Wainwright raised its 12-month price target on the biotech's shares to $14 ahead of the opening bell this morning.

Image source: Getty Images.

Source Fool.com

Like: 0

AGEN

Share